General Information of This Payload
Payload ID
PAY0FOUOJ
Name
Conjugate No.5 Payload
Synonyms
Conjugate No.5 Payload
   Click to Show/Hide
Formula
C46H56N10O9
Isosmiles
C=C(CN12)C[C@@]1([H])C=NC3=CC(OCCCC(NC4=CN(C)C(C(NC5=CC=C(C6=CN(C)C(C(NCCCOC([C@H](C(C)C)NC(CCN)=O)=O)=O)=C6)C=C5)=O)=N4)=O)=C(OC)C=C3C2=O
InChI
InChI=1S/C46H56N10O9/c1-27(2)41(53-40(58)14-15-47)46(62)65-18-8-16-48-43(59)35-20-30(25-54(35)4)29-10-12-31(13-11-29)50-44(60)42-52-38(26-55(42)5)51-39(57)9-7-17-64-37-22-34-33(21-36(37)63-6)45(61)56-24-28(3)19-32(56)23-49-34/h10-13,20-23,25-27,32,41H,3,7-9,14-19,24,47H2,1-2,4-6H3,(H,48,59)(H,50,60)(H,51,57)(H,53,58)/t32-,41-/m0/s1
InChIKey
MIQVMQAOIASPFO-KMAYNHJMSA-N
Pharmaceutical Properties
Molecule Weight
893.015
Polar area
242.6
Complexity
2449.397348
xlogp Value
4.1235
Heavy Count
65
Rot Bonds
20
Hbond acc
14
Hbond Donor
5
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
WO2019126691A1 Conjugate No.5 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
34 nM
Moderate HER2 expression (HER2++)
Method Description
JIMT1 cells were plated at a density of 5000 cells per well and the next day were treated with antibody-PBD conjugate for 3 days.
In Vitro Model Breast ductal carcinoma JIMT1 cells CVCL_2077
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
300 nM
Low HER2 expression (HER2+)
Method Description
MCF-7 cells were plated at a density of 5000 cells per well and the next day were treated with antibody-PBD conjugate for 3 days.
In Vitro Model Invasive breast carcinoma MCF-7 cells CVCL_0031
References
Ref 1 Pyrrolobenzodiazepine antibody conjugates